NCT00561392View on ClinicalTrials.gov

Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease

PHASE4CompletedINTERVENTIONAL

Enrollment

208

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Alzheimer's Disease

Interventions

DRUG

Rivastigmine 5 and 10 cm^2 patch

Trial Locations (1)

Unknown

Novartis Investigative Site, Munich

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY

NCT00561392 - Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease | Biotech Hunter | Biotech Hunter